Robert Moretti

1.5k total citations
16 papers, 1.1k citations indexed

About

Robert Moretti is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Robert Moretti has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 6 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Robert Moretti's work include Asymmetric Synthesis and Catalysis (5 papers), Chemical Reaction Mechanisms (5 papers) and Chemical Synthesis and Analysis (3 papers). Robert Moretti is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Chemical Reaction Mechanisms (5 papers) and Chemical Synthesis and Analysis (3 papers). Robert Moretti collaborates with scholars based in Switzerland and United States. Robert Moretti's co-authors include Wolfgang Oppolzer, Yves P. Auberson, Serge Bischoff, Markus Schmutz, Kurt Lingenhoehl, Hans Allgeier, Phillip Crews, Khisal A. Alvi, Doris L. Slate and Bruce H. Lipshutz and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and The Journal of Organic Chemistry.

In The Last Decade

Robert Moretti

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Moretti Switzerland 15 728 484 202 132 131 16 1.1k
Mitsuru Ohkubo Japan 23 631 0.9× 783 1.6× 154 0.8× 52 0.4× 42 0.3× 60 1.5k
Günter Neef Germany 18 472 0.6× 635 1.3× 400 2.0× 67 0.5× 54 0.4× 71 1.4k
B. L. CHENARD United States 20 957 1.3× 591 1.2× 516 2.6× 107 0.8× 50 0.4× 30 1.6k
Masahiro Yonaga Japan 18 460 0.6× 324 0.7× 96 0.5× 51 0.4× 56 0.4× 35 922
Jeremy Gilmore United Kingdom 14 610 0.8× 385 0.8× 100 0.5× 54 0.4× 101 0.8× 31 966
Marvin M. Hansen United States 17 623 0.9× 389 0.8× 219 1.1× 88 0.7× 32 0.2× 30 1.0k
T. G. Murali Dhar United States 24 1.1k 1.6× 668 1.4× 400 2.0× 82 0.6× 29 0.2× 67 2.0k
Gregor J. Macdonald Belgium 25 698 1.0× 607 1.3× 325 1.6× 41 0.3× 42 0.3× 62 1.5k
Mark T. Goulet United States 26 659 0.9× 710 1.5× 183 0.9× 53 0.4× 29 0.2× 54 1.6k
Luca Gobbi Switzerland 19 487 0.7× 219 0.5× 214 1.1× 85 0.6× 61 0.5× 48 1.1k

Countries citing papers authored by Robert Moretti

Since Specialization
Citations

This map shows the geographic impact of Robert Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Moretti more than expected).

Fields of papers citing papers by Robert Moretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Moretti. The network helps show where Robert Moretti may publish in the future.

Co-authorship network of co-authors of Robert Moretti

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Moretti. A scholar is included among the top collaborators of Robert Moretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Moretti. Robert Moretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Auberson, Yves P., Hans Allgeier, Serge Bischoff, et al.. (2002). 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorganic & Medicinal Chemistry Letters. 12(7). 1099–1102. 188 indexed citations
2.
Auberson, Yves P., Pierre Acklin, Serge Bischoff, et al.. (1999). N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA(glycine) antagonists. Bioorganic & Medicinal Chemistry Letters. 9(2). 249–254. 28 indexed citations
3.
Auberson, Yves P., Serge Bischoff, Robert Moretti, Markus Schmutz, & Siem J. Veenstra. (1998). 5-aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(1). 65–70. 14 indexed citations
4.
Oppolzer, Wolfgang, et al.. (1994). Asymmetric Alkylations of a Sultam‐Derived Glycine Equivalent: Practical preparation of enantiomerically pure α‐amino acids. Helvetica Chimica Acta. 77(8). 2363–2380. 82 indexed citations
5.
Alvi, Khisal A., Jaime Rodrı́guez, Maria Cristina Díaz, et al.. (1993). Protein tyrosine kinase inhibitory properties of planar polycyclics obtained from the marine sponge Xestospongia cf. carbonaria and from total synthesis. The Journal of Organic Chemistry. 58(18). 4871–4880. 50 indexed citations
6.
Alvi, Khisal A., et al.. (1992). Evaluation of new sesquiterpene quinones from two Dysidea sponge species as inhibitors of protein tyrosine kinase. The Journal of Organic Chemistry. 57(24). 6604–6607. 63 indexed citations
7.
Slate, Doris L., et al.. (1992). Marine sponge polyketide inhibitors of protein tyrosine kinase. Biochemical and Biophysical Research Communications. 184(2). 765–772. 64 indexed citations
8.
Lipshutz, Bruce H., et al.. (1989). Progress toward roflamycoin; Synthesis of the C-12 to C-35 section in homochiral form. Tetrahedron Letters. 30(1). 15–18. 41 indexed citations
9.
Oppolzer, Wolfgang, et al.. (1989). Asymmetric alkylations of a sultam-derived glycinate equivalent: practical preparation of enantiomerically pure α-amino acids. Tetrahedron Letters. 30(44). 6009–6010. 75 indexed citations
10.
Oppolzer, Wolfgang, et al.. (1989). Asymmetric alkylation of N-acylsultams: A general route to enantiomerically pure, crystalline C(α,α)-disubstituted carboxylic acid derivatives. Tetrahedron Letters. 30(41). 5603–5606. 141 indexed citations
11.
Behling, James R., Kevin A. Babiak, John S. Ng, et al.. (1988). In situ cuprate formation via transmetalation between vinylstannanes and higher order cyanocuprates. Journal of the American Chemical Society. 110(8). 2641–2643. 109 indexed citations
12.
Oppolzer, Wolfgang & Robert Moretti. (1988). Enantioselective systheses of α-amino acids from 10-sulfonamido-isobornyl esters and di-t-butyl azodicarboxylate. Tetrahedron. 44(17). 5541–5552. 64 indexed citations
13.
Oppolzer, Wolfgang, Robert Moretti, & Gérald Bernardinelli. (1986). Enantioselective synthesis of the alleged structure of norpectinatone. Tetrahedron Letters. 27(39). 4713–4716. 43 indexed citations
14.
Oppolzer, Wolfgang, Rafaël Pedrosa, & Robert Moretti. (1986). Asymmetric syntheses of α-amino acids from α-halogenated 10-sulfonamido-isobornyl esters.. Tetrahedron Letters. 27(7). 831–834. 56 indexed citations
15.
Oppolzer, Wolfgang & Robert Moretti. (1986). Enantioselective Syntheses of α‐Amino Acids from 10‐(Aminosulfonyl)‐2‐bornyl Esters and Di(tert‐butyl) Azodicarboxylate. Preliminary Communication. Helvetica Chimica Acta. 69(8). 1923–1926. 60 indexed citations
16.
Oppolzer, Wolfgang, et al.. (1983). Asymmetric 1,4-additions of coordinated MeCu.BF3 to chiral enoates: enantioselective syntheses of (S)-(−)-citronellic acid. Tetrahedron Letters. 24(45). 4971–4974. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026